Drug Profile
Research programme: cancer companion diagnostics - Cell Signaling Technology/Dako
Latest Information Update: 28 Feb 2019
Price :
$50
*
At a glance
- Originator Dako A/S
- Developer Cell Signaling Technology; Dako A/S
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for research development in Cancer(Diagnosis) in Denmark
- 12 Jan 2015 Dako and Cell Signaling Technology enters into collaboration for the development of companion diagnostics for the treatment of cancer
- 12 Jan 2015 Early research in Cancer (Diagnosis) in Denmark (unspecified route)